Clinical Trial

Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 11, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a randomized, double-blind, placebo-controlled, parallel-group clinical trial. To preliminarily evaluate the safety and efficacy of KHN702 tablets in moderate to severe post-operative pain patients.
Trial Details
NCT Number NCT07277933
Lead Sponsor Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Conditions Postoperative Pain
Enrollment 24 participants
Start Date 2025-12
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-12-11